These days, hospitals are treating increasingly complex patients with multiple co-morbidities. Every hospital must have a strategy to identify such patients, and be capable of providing the appropriate level of care at the right time.
This study, involving close to 20,000 patients and 10 hospitals on three different continents, found that the use of this CDSS when compared with hospitals' previous practices for measuring vitals signs and calculating EWS to activate a RRT is associated with increased survival immediately after RRT treatment; shorter median hospital length of stay in patients in the U.S. hospitals included in the study; and shorter time to complete and record a set of vital signs.
Download this whitepaper today.
Philips is the Exclusive Charter Sponsor of FierceMedicalImaging